Inventor · disambiguated record
John E. Macor
Also filed as: MACOR JOHN · MACOR JOHN E · MACOR JOHN EUGENE
147 granted patents·52 pending applications·1,757 citations·filing 1989–2025
99Inventor score
Top patents by PatentIndex Score
199 records- 0197US9902722B2Biaryl kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Feb 27, 2018·19 cites·13 claims
- 0296USRE49880E[1,2,4]triazolo[1,5-a]pyridinyl substituted indole compoundsBRISTOL MYERS SQUIBB CO·Filed 2022·Granted Mar 26, 2024·2 cites·20 claims
- 0396US6852745B2Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonistsBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Feb 8, 2005·55 cites·30 claims
- 0495US10912766B2[1,2,4]triazolo[1,5-A]pyridinyl substituted indole compoundsBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Feb 9, 2021·6 cites·17 claims
- 0595US6713487B2Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising sameBRISTOL MYERS SQUIBB CO·Filed 2002·Granted Mar 30, 2004·78 cites·15 claims
- 0694US8486952B2Compounds for the reduction of β-amyloid productionBOY KENNETH M·Filed 2010·Granted Jul 16, 2013·34 cites·15 claims
- 0794US6576644B2Quinoline inhibitors of cGMP phosphodiesteraseBRISTOL MYERS SQUIBB CO·Filed 2001·Granted Jun 10, 2003·50 cites·14 claims
- 0894US6110914ASpiroazabicyclic heterocyclic compoundsASTRA AB·Filed 1998·Granted Aug 29, 2000·109 cites·23 claims
- 0994US5051412APharmaceutically active 3-(1,2,5,6-tetrahydropyridyl)-pyrrolopyridinesPFIZER·Filed 1989·Granted Sep 24, 1991·70 cites·9 claims
- 1093US10913738B2Aminotriazolopyridines as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Feb 9, 2021·7 cites·14 claims
- 1193US8637525B2Compounds for the reduction of beta-amyloid productionBOY KENNETH M·Filed 2011·Granted Jan 28, 2014·39 cites·5 claims
- 1292US7378430B2Quinoline inhibitors of cGMP phosphodiesteraseBRISTOL MYERS SQUIBB CO·Filed 2006·Granted May 27, 2008·15 cites·4 claims
- 1392US6638937B2Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonistsBRISTOL MYERS SQUIBB CO·Filed 2000·Granted Oct 28, 2003·26 cites·38 claims
- 1491USRE49893E[1,2,4]triazolo[1,5-a]pyridinyl substituted indole compoundsBRISTOL MYERS SQUIBB CO·Filed 2022·Granted Apr 2, 2024·1 cites·17 claims
- 1591US11180474B2Dimethoxyphenyl substituted indole compounds as TLR7, TLR8 or TLR9 inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Nov 23, 2021·6 cites·14 claims
- 1691US10155760B2Biaryl kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Dec 18, 2018·3 cites·4 claims
- 1791US10071079B2[1,2,4]triazolo[1,5-a]pyridinyl substituted indole compoundsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Sep 11, 2018·6 cites·20 claims
- 1891US8314117B2CGRP receptor antagonistsLUO GUANGLIN·Filed 2010·Granted Nov 20, 2012·23 cites·18 claims
- 1991US7863291B2Quinuclidine compounds as alpha-7 nicotinic acetylcholine receptor ligandsBRISTOL MYERS SQUIBB CO·Filed 2009·Granted Jan 4, 2011·22 cites·14 claims
- 2091US7300936B2α-(N-sulfonamido)acetamide derivatives as β-amyloid inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2002·Granted Nov 27, 2007·46 cites·24 claims
- 2191US5597826ACompositions containing sertraline and a 5-HT1D receptor agonist or antagonistPFIZER·Filed 1994·Granted Jan 28, 1997·97 cites·13 claims
- 2290US10752609B2GSK-3 inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Aug 25, 2020·6 cites·10 claims
- 2390US10723734B2Biaryl kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Jul 28, 2020·2 cites·1 claims
- 2489US9221796B2Selective NR2B antagonistsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Dec 29, 2015·5 cites·12 claims
- 2589US9187506B2(R)-3-((3S,4S)-3-fluoro-4-(4-hydroxyphenyl)piperidin-1-yl)-1-(4-methylbenzyl)pyrrolidin-2-one and its prodrugs for the treatment of psychiatric disordersBRISTOL MEYERS SQUIBB CO·Filed 2015·Granted Nov 17, 2015·5 cites·12 claims
- 2689US8481546B2CGRP receptor antagonistCHATURVEDULA PRASAD V·Filed 2011·Granted Jul 9, 2013·17 cites·3 claims
- 2789US7754732B2Spirocyclic anti-migraine compoundsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Jul 13, 2010·13 cites·32 claims
- 2889US2024360131A1Biaryl kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2024·Application pending·0 cites
- 2988US7786122B2α-(N-sulfonamido)acetamide derivatives as β-amyloid inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Aug 31, 2010·12 cites·1 claims
- 3088US7314883B2Anti-migraine treatmentsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Jan 1, 2008·12 cites·36 claims
- 3188US5545644AIndole derivativesPFIZER·Filed 1995·Granted Aug 13, 1996·95 cites·18 claims
- 3287US8309577B2Quinuclidine compounds as α-7 nicotinic acetylcholine receptor ligandsCOOK II JAMES H·Filed 2009·Granted Nov 13, 2012·10 cites·18 claims
- 3387US7842808B2Anti-migraine spirocyclesBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Nov 30, 2010·13 cites·36 claims
- 3487US7388007B2Gamma-lactams as beta-secretase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Jun 17, 2008·6 cites·8 claims
- 3587US7384958B2Quinoline inhibitors of cGMP phosphodiesteraseBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Jun 10, 2008·7 cites·10 claims
- 3686US10660877B2Pyridyl substituted indole compoundsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted May 26, 2020·6 cites·18 claims
- 3786US7902218B2Substituted tetrahydroisoquinolines as β-secretase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Mar 8, 2011·5 cites·7 claims
- 3886US7772244B2Therapeutic agents for the treatment of migraineBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Aug 10, 2010·12 cites·14 claims
- 3986US6835737B2Quinoline inhibitors of cGMP phosphodiesteraseBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Dec 28, 2004·16 cites·11 claims
- 4086US6369224B1CompoundsASTRAZENECA AB·Filed 2000·Granted Apr 9, 2002·18 cites·1 claims
- 4186US6316438B1Fused pyridopyridazine inhibitors of cGMP phosphodiesteraseBRISTOL MYERS SQUIBB CO·Filed 2000·Granted Nov 13, 2001·46 cites·20 claims
- 4286US2023255941A1[1,2,4]triazolo[1,5-a]pyridinyl substituted indole compoundsBRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 4384US5578612AIndole derivativesPFIZER·Filed 1995·Granted Nov 26, 1996·62 cites·24 claims
- 4484US2023192645A1Indole carboxamide compoundsBRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 4583US7105516B2Compounds for the treatment of premature ejaculationBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Sep 12, 2006·15 cites·59 claims
- 4683US6835741B2Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonistsBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Dec 28, 2004·10 cites·35 claims
- 4783US6706878B2Spiroazabicyclic heterocyclic compoundsASTRAZENECA AB·Filed 2003·Granted Mar 16, 2004·13 cites·11 claims
- 4882US7408071B2N-aryl pyrrolidine derivatives as beta-secretase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Aug 5, 2008·4 cites·7 claims
- 4982US6255306B14-indole derivatives as serotonin agonists and antagonistsFiled 1998·Granted Jul 3, 2001·54 cites·13 claims
- 5081US11440913B2Aminoimidazopyridazines as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Sep 13, 2022·2 cites·14 claims
Showing the top 50 of 199 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when John E. Macor files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →